2'-DEOXY-L-CYTIDINE

2'-DEOXY-L-CYTIDINE Basic information
Product Name:2'-DEOXY-L-CYTIDINE
Synonyms:BETA-L-2'-DEOXYCYTIDINE;4-AMino-1-((2R,4R,5S)-4-hydroxy-5-(hydroxyMethyl)tetrahydrofuran-2-yl)pyriMidin-2(1H)-one;L-2'-deoxycytidine;2'-DEOXY-L-CYTIDINE;4-amino-1-[(2S,4R,5S)-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]pyrimidin-2-one;2(1H)-Pyrimidinone, 4-amino-1-(2-deoxy-b-L-erythro-pentofuranosyl)-;2(1H)-Pyrimidinone, 4-amino-1-(2-deoxy-β-L-erythro-pentofuranosyl)-;Torcitabine
CAS:40093-94-5
MF:C9H13N3O4
MW:227.22
EINECS:500-100-4
Product Categories:
Mol File:40093-94-5.mol
2'-DEOXY-L-CYTIDINE Structure
2'-DEOXY-L-CYTIDINE Chemical Properties
Boiling point 497.6±55.0 °C(Predicted)
density 1.73±0.1 g/cm3(Predicted)
storage temp. Store at -20°C
solubility DMSO: 250 mg/mL (1100.26 mM)
pka14.03±0.60(Predicted)
Water Solubility Water: 250 mg/mL (1100.26 mM)
Safety Information
MSDS Information
2'-DEOXY-L-CYTIDINE Usage And Synthesis
DescriptionTorcitabine (b-L-2u-deoxycytidine) (L-dC) is the b-L-enantiomer of the natural nucleoside D-cytidine. The drug is currently under development by Idenix as an antiviral agent for the treatment of chronic hepatitis B virus infection. Torcitabine has poor oral bioavailability, but its 3u,5u-divaline ester (val-L-dC) and the 3u-monovaline ester, valtorcitabine dihydrochloride, have excellent oral bioavailability and consequently the torcitabine prodrug, valtorcitabine, has replaced torcitabine in clinical development.
UsesTorcitabine and its prodrug, valtorcitabine, are investigational drugs being developed solely for the treatment of chronic HBV infection. Torcitabine itself has undergone preliminary phase I/II clinical trials in HBeAg-positive patients, initially as the 3u,5u-divalyl prodrug in escalating doses of 50, 100, 200, and 400 mg/day, but later as the more stable monovaline ester form, valtorcitabine dihydrochloride, and administered to four cohorts in doses of 300, 600, 900, and 1200 mg/ day for 28 days.
2'-DEOXY-L-CYTIDINE Preparation Products And Raw materials
4-(CYCLOPROPYLAMINO)-5-FLUORO-1-β-L-RIBOFURANOSYLPYRIMIDINONE N4-Benzoyl-3'-deoxy-D-cytidine 2'-O,3'-O,5'-O-Tribenzoylcytidine 2'-DEOXY-BETA-L-CYTIDINE, [5,6-3H]- VALTORCITABINE 2'-DEOXY-L-CYTIDINE 2'-Amino-2'-deoxy-D-cytidine 5-FLUORO-1-(β-L-RIBOFURANOSYL)CYTOSINE (4-AMINO-5-FLUORO-1-β-L-RIBOFURANOSYLPYRIMIDINONE) 2'-DEOXY-D-CYTIDINE L-Cytidine 3'-AZIDO-2'-DEOXY-D-CYTIDINE N4-Etheno2'-deoxy-D-cytidine 5-Aza-2'-deoxy-D-cytidine 3'-Deoxy-D-cytidine 2'-DEOXY-D-CYTIDINE 2'-DEOXY-L-CYTIDINE-5'-TRIPHOSPHATE LITHIUM SALT 2'-deoxy-(fluoromethylene)cytidine BETA-L-CYTIDINE, [3H]-

Email:[email protected] [email protected]
Copyright © 2024 Mywellwork.com All rights reserved.